GB COVID-19 Ag POCT
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
General Biologicals Corporation
Hsinchu, Taiwan
- Ownership
- Private
- Development stage
- Commercial
01
Overview
GBC is a leading Taiwan-based developer of in vitro diagnostic devices and reagents with a global presence. Its CLIA systems are commercially available in over 40 countries. The company’s lead therapeutic candidate, the antimicrobial peptide P113 for oral candidiasis and related indications, has completed a promising Phase IIb clinical trial. GBC continues to expand its portfolio into precision medicine, digital health services, liquid biopsy technologies, and biologics manufacturing.
- Therapeutic areas
- OncologyInfectious DiseasesEndocrinologyGastroenterologyWomen's Health
- Modalities
- Diagnostic deviceChemiluminescent immunoassay (CLIA)Real-time PCR kitPeptide (for P113 antimicrobial peptide drug)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ITRI – Industrial Technology Research Institute of TaiwanInternational hospital/lab partners across >40 countriesOngoing expansion into Middle East/Southeast Asia markets
Beyond the preview
Go deeper on General Biologicals Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on General Biologicals Corporation.